Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$147,691
+$98,813 QoQ
Shares Held
10,932
+178.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $1,784,999 across 41 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
681 | $403,819 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,694 | $322,103 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,432 | $188,651 | |
| 4 | ZTS |
Zoetis Inc.
|
1,527 | $180,506 | |
| 5 | VTRS |
Viatris Inc
This page
|
10,932 | $147,691 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,343 | $80,432 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
1,030 | $79,207 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
2,408 | $57,623 |
All Filings in VTRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $147,691 | 10,932 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $48,878 | 3,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $601,840 | 60,792 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,453 | 4,866 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $22,489 | 2,582 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,381 | 2,119 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $16,997 | 1,464 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $13,829 | 1,301 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,671 | 140 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,646 | 152 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,190 | 425 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,201 | 421 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,021 | 418 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $4,618 | 415 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $60,210 | 7,067 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $76,493 | 7,306 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $78,640 | 7,228 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $97,754 | 7,225 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $97,885 | 7,224 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $83,453 | 5,840 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $23,987 | 1,280 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||